263 related articles for article (PubMed ID: 16026543)
1. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
2. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate abnormalities in exostosis growth plates.
Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG
Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
[TBL] [Abstract][Full Text] [Related]
5. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of heparan sulfate in EXT1-deficient cells.
Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
[TBL] [Abstract][Full Text] [Related]
7. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
8. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
9. A splice-site mutation leads to haploinsufficiency of EXT2 mRNA for a dominant trait in a large family with multiple osteochondromas.
Yang L; Hui WS; Chan WC; Ng VC; Yam TH; Leung HC; Huang JD; Shum DK; Jie Q; Cheung KM; Cheah KS; Luo Z; Chan D
J Orthop Res; 2010 Nov; 28(11):1522-30. PubMed ID: 20872591
[TBL] [Abstract][Full Text] [Related]
10. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.
Zak BM; Schuksz M; Koyama E; Mundy C; Wells DE; Yamaguchi Y; Pacifici M; Esko JD
Bone; 2011 May; 48(5):979-87. PubMed ID: 21310272
[TBL] [Abstract][Full Text] [Related]
11. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
Pacifici M
Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
[TBL] [Abstract][Full Text] [Related]
12. EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development.
Hilton MJ; Gutiérrez L; Martinez DA; Wells DE
Bone; 2005 Mar; 36(3):379-86. PubMed ID: 15777636
[TBL] [Abstract][Full Text] [Related]
13. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice.
Morimoto K; Shimizu T; Furukawa K; Morio H; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2002 Apr; 292(4):999-1009. PubMed ID: 11944914
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
16. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
[TBL] [Abstract][Full Text] [Related]
17. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.
Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L
J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647
[TBL] [Abstract][Full Text] [Related]
18. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
19. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.
Trebicz-Geffen M; Robinson D; Evron Z; Glaser T; Fridkin M; Kollander Y; Vlodavsky I; Ilan N; Law KF; Cheah KS; Chan D; Werner H; Nevo Z
Int J Exp Pathol; 2008 Oct; 89(5):321-31. PubMed ID: 18452536
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling.
Kawashima K; Ogawa H; Komura S; Ishihara T; Yamaguchi Y; Akiyama H; Matsumoto K
Osteoarthritis Cartilage; 2020 Nov; 28(11):1459-1470. PubMed ID: 32818603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]